[Summary of the NHG practice guideline 'Lower urinary tract symptoms in men']

Ned Tijdschr Geneeskd. 2013;157(18):A6178.
[Article in Dutch]

Abstract

In general practice, lower urinary tract symptoms (LUTS) in men are usually not attributable to specific disorders. Prostate cancer is rarely the cause of LUTS. Education, counselling, and non-pharmaceutical advice form the basis for treatment of LUTS. Only when these measures do not relieve the patient's symptoms sufficiently, drug therapy could be considered. Alpha-blockers are the drugs of first choice and are also recommended when transurethral catheterization is needed for acute urinary retention. The effect of medication on LUTS is limited and largely based on placebo effect. The effectiveness of prostate cancer screening is a subject of debate; therefore patients asking for a PSA test should be informed about the benefits and harms of measuring PSA before having a test. A PSA value > 4 ng/ml, or abnormal results on digital rectal examination should prompt further diagnostic evaluation.

Publication types

  • Review

MeSH terms

  • Adrenergic alpha-Antagonists / therapeutic use
  • Digital Rectal Examination
  • Early Detection of Cancer
  • General Practice / standards*
  • Humans
  • Lower Urinary Tract Symptoms / diagnosis*
  • Lower Urinary Tract Symptoms / drug therapy
  • Lower Urinary Tract Symptoms / etiology
  • Male
  • Physical Examination
  • Placebo Effect
  • Practice Guidelines as Topic*
  • Prostate-Specific Antigen / analysis
  • Prostatic Neoplasms / complications
  • Prostatic Neoplasms / diagnosis
  • Urinary Retention / diagnosis*
  • Urinary Retention / drug therapy
  • Urinary Retention / etiology

Substances

  • Adrenergic alpha-Antagonists
  • Prostate-Specific Antigen